# Comparative inhibitory effects of phillyrin and phillygenin on elastase: mechanisms and therapeutic potential

**Authors:** Wenhui Zhang, Jinfeng Fu, Hongliu Yao, Yongxue Li, Jingang Mo, Yi Guan, Yan Wang, Lihao Lin

PMC · DOI: 10.3389/fnut.2026.1723757 · Frontiers in Nutrition · 2026-02-11

## TL;DR

This study compares how two compounds from Forsythia inhibit elastase, a protease linked to lung and inflammatory diseases, and finds that phillygenin is more effective.

## Contribution

The study reveals the molecular mechanisms and relative efficacy of phillyrin and phillygenin as elastase inhibitors.

## Key findings

- Phillygenin showed stronger elastase inhibition than phillyrin with lower IC50 and Ki values.
- Spectroscopy showed ligand-induced structural changes in elastase, including increased α-helix and random coil content.
- Molecular docking identified multiple interaction types, including π-cation, hydrogen bonds, and hydrophobic forces.

## Abstract

Elastase, a serine protease, has been implicated in chronic obstructive pulmonary disease and systemic inflammatory response syndrome. In this study, we evaluated the effects of phillyrin and phillygenin, 2 major Forsythia lignans, on elastase inhibition. Both compounds exhibited competitive inhibition, as confirmed by enzymatic kinetics, spectroscopy, and molecular docking. Phillygenin exhibited stronger activity (IC50 0.5 mmol/L, Ki 4.0 × 10−4 mol/L) than phillyrin (IC50 1.5 mmol/L, Ki 9.7 × 10−4 mol/L), likely due to reduced steric hindrance. Spectroscopic analysis revealed ligand-induced conformational changes in elastase, characterized by increased α-helix and random coil content and decreased β-sheet structures. Docking revealed interactions involving π-cation, π-sigma, hydrogen bonds, hydrophobic forces, electrostatics, and van der Waals effects. These results provide mechanistic insights into the inhibitory effects of phillyrin and phillygenin and highlight their potential as therapeutic agents for elastase-related diseases.

Diagram illustrating enzyme activity and interaction studies. Left: Lineweaver-Burk plots analyzing enzyme kinetics. Center: Chemical structures and a protein model labeled for activity evaluation. Right: Graphs showing interaction measurements, including spectra and protein structure representations, emphasizing structural changes and binding activity.

## Linked entities

- **Proteins:** cela1.2.L (chymotrypsin like elastase 1, gene 2 L homeolog)
- **Chemicals:** phillyrin (PubChem CID 101712), phillygenin (PubChem CID 3083590)
- **Diseases:** chronic obstructive pulmonary disease (MONDO:0005002)

## Full-text entities

- **Genes:** ELANE (elastase, neutrophil expressed) [NCBI Gene 1991] {aka ELA2, GE, HLE, HNE, NE, PMN-E}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, ELN (elastin) [NCBI Gene 2006] {aka ADCL1, SVAS, WBS, WS}
- **Diseases:** COPD (MESH:D029424), ARDS (MESH:D012128), diseases (MESH:D004194), inflammation (MESH:D007249), systemic inflammatory response syndrome (MESH:D018746), acute lung injury (MESH:D055371), pulmonary fibrosis (MESH:D011658), Pseudomonas aeruginosa infection (MESH:D011552), toxicity (MESH:D064420)
- **Chemicals:** amide (MESH:D000577), Tyr (MESH:D014443), aglycone (MESH:C458179), sivelestat (MESH:C069195), oxygen (MESH:D010100), glucoside (MESH:D005960), histidine (MESH:D006639), nitrogen (MESH:D009584), carbon (MESH:D002244), polyphenols (MESH:D059808), Phillygenin (MESH:C542294), Trp (MESH:D014364), hydrogen (MESH:D006859), PBS (MESH:D007854), Thr (MESH:D013912), glycoside (MESH:D006027), Aphillyrin (-), amino acid (MESH:D000596), lignan (MESH:D017705), Arg (MESH:D001120), Phillyrin (MESH:C075528), Ser (MESH:D012694)
- **Species:** Haplochromis sp. LE (species) [taxon 1202858], Forsythia suspensa (species) [taxon 126418], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12932445/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12932445/full.md

## References

72 references — full list in the complete paper: https://tomesphere.com/paper/PMC12932445/full.md

---
Source: https://tomesphere.com/paper/PMC12932445